Loc646329 sponges miR-21 to reduce RAS/MAP kinase signaling pathway in oral squamous cell carcinoma (OSCC).

Autor: Adereh A; Yasuj University of Medical Science, Yasuj, Iran., Amini P; Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran., Fateh A; Shahid Sadoughi University of Medical Sciences, Yazd, Iran., Faghihkhorasani F; Department of Cardiology, Internal Medicine, The first affiliated Hospital of Xi'an Jiaotong University, Xian, Shaanxi Province, 710061, China., Khdakarim N; Assistant Professor of Hematology & Oncology, Department of Internal Medicine, School of Medicine, Hazrat-E Rasool General Hospital, Iran University of Medical Sciences, Tehran, Iran., Marashi SM; Tehran University of Medical Sciences, Tehran, Iran., Ahadi S; School of Medicine, Jondishapour University of Medical Sciences, Ahvaz, Iran., Nayebzadeh P; University of Georgia, Tbilisi, Georgia., Khanmirzaei A; Faculty of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran. amirk.mirzaei@gmail.com.

Publikováno v: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Dec 14. Date of Electronic Publication: 2024 Dec 14.